Radiation boost trial aims to help tough lung cancer cases
NCT ID NCT05403723
Summary
This study is testing if adding a short, precise course of radiation (SBRT) to standard immunotherapy and chemotherapy is safe for people with extensive-stage small cell lung cancer. It focuses on patients whose cancer does not shrink enough after the first two cycles of standard drug treatment. The goal is to see if this 'adaptive' radiation approach can help control the disease better for these patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTENSIVE STAGE SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Maryland Greenebaum Comprehensive Cancer Center
Baltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.